Applied DNA Sciences, Inc. Financial Flexibility Index
Applied DNA Sciences, Inc. financial flexibility index. Applied DNA Sciences, Inc. (BNBX) has a Financial Flexibility Index of -1.36x as of March 2026. Free cash flow of $-2.05 Million (operating CF $-2.05 Million minus capex $3.00) represents -1% of total liabilities ($1.50 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Applied DNA Sciences, Inc. (2021–2025)
Financial flexibility index of Applied DNA Sciences, Inc. from 2021 to 2025. Historical Financial Flexibility Index trend for Applied DNA Sciences, Inc. across 5 annual periods. Check BNBX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Applied DNA Sciences, Inc. Financial Flexibility Index by Year (2021–2025)
Applied DNA Sciences, Inc. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Applied DNA Sciences, Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Applied DNA Sciences, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.89x | $-12.21 Million | $-12.52 Million | $2.50 Million | ▼ -40.5% |
| 2024 | -3.48x | $-13.30 Million | $-13.71 Million | $3.82 Million | ▼ -397.9% |
| 2023 | -0.70x | $-6.14 Million | $-6.22 Million | $8.78 Million | ▲ +22.9% |
| 2022 | -0.91x | $-8.49 Million | $-8.98 Million | $9.36 Million | ▲ +72.4% |
| 2021 | -3.28x | $-10.84 Million | $-13.39 Million | $3.30 Million | — |